APO B750 (Balsalazide 750 mg)
Pill imprint APO B750 has been identified as Balsalazide disodium 750 mg.
Balsalazide is used in the treatment of ulcerative colitis; crohn's disease; ulcerative colitis, active and belongs to the drug class 5-aminosalicylates. There is no proven risk in humans during pregnancy. Balsalazide 750 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO B750
- Strength:
- 750 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- 5-aminosalicylates
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-2575
- Inactive Ingredients:
- silicon dioxide
magnesium stearate
titanium dioxide
propylene glycol
ammonia
shellac
ferric oxide red
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0799 | Amerisource Health Services |
| 42291-0157 | AvKare, Inc. |
Note: Inactive ingredients may vary.
More about balsalazide
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
